Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Stoke Therapeutics, Inc. (STOK)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Stoke Therapeutics, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Stoke Therapeutics, Inc. since 2005.
The reporting company's ticker symbol is STOK. The reporting company's CIK number is 1623526.
The total value of stock buying since 2005 is $65,726,446.
The total value of stock sales since 2005 is $471,639.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-06-21||Atp Iii Gp, Ltd.||Buy||1,388,889||18.00||25,000,002|
|2019-06-21||Harrison Seth Loring||Buy||1,388,889||18.00||25,000,002|
Insider trading activities including stock purchases, stock sales, and option exercises of STOK listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Stoke Therapeutics, Inc. (symbol STOK, CIK number 1623526) see the Securities and Exchange Commission (SEC) website.